$CYAN
CYANOTECH CORP

2018 Q3 Form 10-Q Financial Statement

#000143774918020377 Filed on November 13, 2018

View on sec.gov

Income Statement

Concept 2018 Q3 2017 Q3
Revenue $6.954M $8.055M
YoY Change -13.67% -18.32%
Cost Of Revenue $4.669M $4.435M
YoY Change 5.28% -25.8%
Gross Profit $2.285M $3.620M
YoY Change -36.88% -6.82%
Gross Profit Margin 32.86% 44.94%
Selling, General & Admin $3.078M $2.852M
YoY Change 7.92% -18.19%
% of Gross Profit 134.7% 78.78%
Research & Development $211.0K $149.0K
YoY Change 41.61% -1.97%
% of Gross Profit 9.23% 4.12%
Depreciation & Amortization $475.0K $460.0K
YoY Change 3.26% -11.54%
% of Gross Profit 20.79% 12.71%
Operating Expenses $3.289M $3.001M
YoY Change 9.6% -17.51%
Operating Profit -$1.004M $619.0K
YoY Change -262.2% 150.61%
Interest Expense $150.0K -$133.0K
YoY Change -212.78% 9.02%
% of Operating Profit -21.49%
Other Income/Expense, Net
YoY Change
Pretax Income -$1.154M $486.0K
YoY Change -337.45% 288.8%
Income Tax -$18.00K $11.00K
% Of Pretax Income 2.26%
Net Earnings -$1.136M $475.0K
YoY Change -339.16% 379.8%
Net Earnings / Revenue -16.34% 5.9%
Basic Earnings Per Share -$0.20 $0.08
Diluted Earnings Per Share -$0.20 $0.08
COMMON SHARES
Basic Shares Outstanding 5.806M 5.709M
Diluted Shares Outstanding 5.806M 5.771M

Balance Sheet

Concept 2018 Q3 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $660.0K $2.100M
YoY Change -68.57% 1.94%
Cash & Equivalents $663.0K $2.102M
Short-Term Investments
Other Short-Term Assets $700.0K $450.0K
YoY Change 55.56% -45.78%
Inventory $10.44M $9.315M
Prepaid Expenses
Receivables $1.882M $1.541M
Other Receivables $0.00 $0.00
Total Short-Term Assets $13.68M $13.41M
YoY Change 2.08% 0.02%
LONG-TERM ASSETS
Property, Plant & Equipment $15.12M $16.02M
YoY Change -5.62% -6.54%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $298.0K $251.0K
YoY Change 18.73% -32.89%
Total Long-Term Assets $15.42M $16.27M
YoY Change -5.25% -7.11%
TOTAL ASSETS
Total Short-Term Assets $13.68M $13.41M
Total Long-Term Assets $15.42M $16.27M
Total Assets $29.10M $29.68M
YoY Change -1.94% -4.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.295M $3.473M
YoY Change 23.67% -16.99%
Accrued Expenses $811.0K $1.012M
YoY Change -19.86% -32.67%
Deferred Revenue
YoY Change
Short-Term Debt $1.750M $500.0K
YoY Change 250.0% -18.03%
Long-Term Debt Due $660.0K $630.0K
YoY Change 4.76% 3.28%
Total Short-Term Liabilities $7.602M $5.683M
YoY Change 33.77% -18.27%
LONG-TERM LIABILITIES
Long-Term Debt $5.480M $5.960M
YoY Change -8.05% -9.01%
Other Long-Term Liabilities $90.00K $110.0K
YoY Change -18.18% 175.0%
Total Long-Term Liabilities $5.570M $6.070M
YoY Change -8.24% -7.89%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.602M $5.683M
Total Long-Term Liabilities $5.570M $6.070M
Total Liabilities $13.18M $11.75M
YoY Change 12.13% -13.68%
SHAREHOLDERS EQUITY
Retained Earnings -$16.47M -$14.11M
YoY Change 16.75% -2.45%
Common Stock $117.0K $115.0K
YoY Change 1.74% 1.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $15.93M $17.93M
YoY Change
Total Liabilities & Shareholders Equity $29.10M $29.68M
YoY Change -1.94% -4.02%

Cashflow Statement

Concept 2018 Q3 2017 Q3
OPERATING ACTIVITIES
Net Income -$1.136M $475.0K
YoY Change -339.16% 379.8%
Depreciation, Depletion And Amortization $475.0K $460.0K
YoY Change 3.26% -11.54%
Cash From Operating Activities -$440.0K $1.180M
YoY Change -137.29% 59.46%
INVESTING ACTIVITIES
Capital Expenditures -$170.0K -$220.0K
YoY Change -22.73% 100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$170.0K -$220.0K
YoY Change -22.73% 100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 340.0K -160.0K
YoY Change -312.5% 23.08%
NET CHANGE
Cash From Operating Activities -440.0K 1.180M
Cash From Investing Activities -170.0K -220.0K
Cash From Financing Activities 340.0K -160.0K
Net Change In Cash -270.0K 800.0K
YoY Change -133.75% 60.0%
FREE CASH FLOW
Cash From Operating Activities -$440.0K $1.180M
Capital Expenditures -$170.0K -$220.0K
Free Cash Flow -$270.0K $1.400M
YoY Change -119.29% 64.71%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q3 cyan Inventory Abnormal Production Costs
InventoryAbnormalProductionCosts
0
cyan Inventory Abnormal Production Costs
InventoryAbnormalProductionCosts
250000
CY2017Q3 cyan Inventory Abnormal Production Costs
InventoryAbnormalProductionCosts
0
cyan Inventory Abnormal Production Costs
InventoryAbnormalProductionCosts
0
CY2018Q3 cyan Longterm Debt And Capital Lease Obligations Net Of Issuance Costs
LongtermDebtAndCapitalLeaseObligationsNetOfIssuanceCosts
5482000
CY2018Q1 cyan Longterm Debt And Capital Lease Obligations Net Of Issuance Costs
LongtermDebtAndCapitalLeaseObligationsNetOfIssuanceCosts
5790000
CY2018Q3 cyan Non Inventoriable Fixed Costs
NonInventoriableFixedCosts
16000
cyan Non Inventoriable Fixed Costs
NonInventoriableFixedCosts
141000
CY2017Q3 cyan Non Inventoriable Fixed Costs
NonInventoriableFixedCosts
75000
cyan Non Inventoriable Fixed Costs
NonInventoriableFixedCosts
84000
CY2018Q3 cyan Number Of Shareholder Approved Sharebased Compensation Plans
NumberOfShareholderApprovedSharebasedCompensationPlans
2
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Small Business
EntitySmallBusiness
true
CY2018Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4295000
CY2018Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3527000
CY2018Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1882000
CY2018Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2664000
CY2018Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
811000
CY2018Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
892000
CY2018Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
568000
CY2018Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
707000
CY2018Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18296000
CY2018Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
17346000
CY2018Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
32280000
CY2018Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
32051000
CY2018Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
27000
CY2018Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
27000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
39000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
32000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2018 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2018Q3 us-gaap Assets
Assets
29104000
CY2018Q1 us-gaap Assets
Assets
29707000
CY2018Q3 us-gaap Assets Current
AssetsCurrent
13684000
CY2018Q1 us-gaap Assets Current
AssetsCurrent
13617000
CY2018Q3 us-gaap Capital Lease Obligations
CapitalLeaseObligations
115000
CY2018Q1 us-gaap Capital Lease Obligations
CapitalLeaseObligations
148000
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
663000
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1329000
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1407000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
695000
CY2018Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1394000
CY2017Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1407000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
663000
CY2017Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2102000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-731000
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.02
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.02
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000000
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000000
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5836110000
CY2018Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5772032000
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5836110000
CY2018Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5772032000
CY2018Q3 us-gaap Common Stock Value
CommonStockValue
117000
CY2018Q1 us-gaap Common Stock Value
CommonStockValue
115000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-weight: bold;">Concentration of Accounts Receivable and Revenues</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:7.5pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:28.5pt;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 45pt;">At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">62%</div> of the Company&#x2019;s accounts receivable was comprised of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> customer balances of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">38%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24%,</div> respectively. At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 31, 2018, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">76%</div> of the Company&#x2019;s accounts receivable was comprised of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> customer balances of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">45%,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15%,</div> respectively. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Two</div> customers accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">60%</div> of total net sales for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>comprised of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">38%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">22%,</div> respectively. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Two</div> customers accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">46%</div> of total net sales for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>comprised of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">32%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14%,</div> respectively. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Two</div> customers accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">59%</div> of total net sales for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>comprised of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">34%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25%,</div> respectively. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Two</div> customers accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">45%</div> of total net sales for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>comprised of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">32%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13%,</div> respectively.</div></div></div>
CY2018Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4669000
CY2017Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4435000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9978000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9641000
CY2018Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
606000
CY2018Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
549000
CY2018Q3 us-gaap Customer Deposits Current
CustomerDepositsCurrent
83000
CY2018Q1 us-gaap Customer Deposits Current
CustomerDepositsCurrent
133000
CY2018Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
216000
CY2018Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
233000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
950000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
938000
CY2017Q3 us-gaap Dilutive Securities
DilutiveSecurities
us-gaap Dilutive Securities
DilutiveSecurities
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.42
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.17
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.016
CY2017Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.022
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.021
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-32000
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1481000
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1412000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2853000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2764000
CY2018Q3 us-gaap Gross Profit
GrossProfit
2285000
CY2017Q3 us-gaap Gross Profit
GrossProfit
3620000
us-gaap Gross Profit
GrossProfit
4121000
us-gaap Gross Profit
GrossProfit
7223000
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1154000
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
486000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2451000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
998000
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-18000
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-40000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21000
CY2018Q3 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
-18000
CY2017Q3 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
11000
us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
-40000
us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
21000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
768000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-193000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-782000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-594000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-81000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1000
us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
-50000
us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
-47000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1405000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1343000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-10000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-5000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
139000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-66000
CY2018Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-150000
CY2017Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-133000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-280000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-241000
us-gaap Interest Paid Net
InterestPaidNet
219000
us-gaap Interest Paid Net
InterestPaidNet
210000
CY2018Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
5248000
CY2018Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
5878000
CY2018Q3 us-gaap Inventory Net
InventoryNet
10439000
CY2018Q1 us-gaap Inventory Net
InventoryNet
9034000
CY2018Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
516000
CY2018Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
410000
CY2018Q3 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
158000
CY2018Q1 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
144000
CY2018Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4517000
CY2018Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2602000
CY2018Q3 us-gaap Liabilities
Liabilities
13177000
CY2018Q1 us-gaap Liabilities
Liabilities
11600000
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29104000
CY2018Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29707000
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
7602000
CY2018Q1 us-gaap Liabilities Current
LiabilitiesCurrent
5707000
CY2018Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
1750000
CY2018Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
500000
CY2018Q3 us-gaap Long Term Debt
LongTermDebt
6246000
CY2018Q1 us-gaap Long Term Debt
LongTermDebt
6530000
CY2018Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
5698000
CY2018Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
6023000
CY2018Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
663000
CY2018Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
655000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
920000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-415000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-338000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-281000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1313000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1391000
us-gaap Net Income Loss
NetIncomeLoss
-2411000
us-gaap Net Income Loss
NetIncomeLoss
977000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-1136000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
475000
CY2017Q3 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
475000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
3289000
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
3001000
us-gaap Operating Expenses
OperatingExpenses
6292000
us-gaap Operating Expenses
OperatingExpenses
5984000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1004000
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
619000
us-gaap Operating Income Loss
OperatingIncomeLoss
-2171000
us-gaap Operating Income Loss
OperatingIncomeLoss
1239000
CY2018Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
243000
CY2018Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
185000
CY2018Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
298000
CY2018Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
291000
CY2018Q3 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
93000
CY2018Q1 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
103000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
32000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
338000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
281000
CY2018Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000000
CY2018Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000000
CY2018Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
700000
CY2018Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
590000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-weight: bold;">Reclassification</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 45pt;">Certain amounts previously reported in the fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> consolidated financial statements have been reclassified to conform with the fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> financial presentation. These reclassifications have <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> impact on net income.</div></div></div>
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
1250000
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-111000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
19000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2000
CY2018Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
32812000
CY2018Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
32531000
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15122000
CY2018Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15734000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
33000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
46000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
284000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
260000
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
211000
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
149000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
419000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
291000
CY2018Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
65000
CY2017Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
CY2018Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
CY2018Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
CY2018Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
65000
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16470000
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14059000
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6954000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14099000
CY2017Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8055000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16864000
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y328D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y182D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.81
CY2018Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.83
CY2018Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1597000
CY2017Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1440000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3020000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2929000
us-gaap Share Based Compensation
ShareBasedCompensation
244000
us-gaap Share Based Compensation
ShareBasedCompensation
341000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
632757
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
1650000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1294040
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
483400
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.15
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
5000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
675300
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
59182
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
589400
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
578400
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.06
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.06
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.85
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.75
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2018Q3 us-gaap Share Price
SharePrice
3.35
CY2018Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
59182
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y219D
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
120000
CY2018Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
95000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
6000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
15927000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
18107000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
25000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
1.71
CY2018Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 45pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosures of any contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the periods reported.&nbsp; Management reviews these estimates and assumptions periodically and reflects the effect of revisions in the period that they are determined to be necessary.&nbsp; Actual results could differ from those estimates and assumptions.</div></div></div>
CY2017Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
62000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
46000
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5806000
CY2017Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5771000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5796000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5743000
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5806000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5796000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5743000
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5806000
CY2017Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5709000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5796000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5697000

Files In Submission

Name View Source Status
0001437749-18-020377-index-headers.html Edgar Link pending
0001437749-18-020377-index.html Edgar Link pending
0001437749-18-020377.txt Edgar Link pending
0001437749-18-020377-xbrl.zip Edgar Link pending
a1.jpg Edgar Link pending
cyan-20180930.xml Edgar Link completed
cyan-20180930.xsd Edgar Link pending
cyan-20180930_cal.xml Edgar Link unprocessable
cyan-20180930_def.xml Edgar Link unprocessable
cyan-20180930_lab.xml Edgar Link unprocessable
cyan-20180930_pre.xml Edgar Link unprocessable
cyan20180930_10q.htm Edgar Link pending
ex_126383.htm Edgar Link pending
ex_126384.htm Edgar Link pending
ex_126385.htm Edgar Link pending
ex_128522.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending